Quantitative evaluation of the impact of heterogeneity correction on left breast cancer radiotherapy performed with respiratory gating

Mohamed Fdhila, Isabelle Gabelle-Flandin, Jacques Balosso, Abdulhamid Chaikh


Purpose: Our objective was to assess the impact of a heterogeneity correction to the calculated dose for left breast cancer gated radiotherapy.

Methods: Ten patients with left breast cancer were studied. For each patient 2 treatment plans were generated. In plan 1 the dose was calculated using a Pencil Beam Convolution (PBC) algorithm. In plan 2 the dose was calculated using the Modified Batho's (MB) density correction method. To compare the two plans a dosimetric analysis was carried out including monitor units (MU), isodose curves, cumulative and differential dose volume histograms (cDVH, dDVH), coverage index, conformity index for target volume and the two dimensional (2D) gamma index (γ). Wilcoxon signed rank and Spearmen's tests were used to calculate p-values and correlation coefficients (r), respectively.

Results: MB method reduced the MU by on average 1.12 ± 5.33%. The analysis of cDVH showed that the MB method calculated significantly higher doses for target volumes, lung and heart, p < 0.05. The data demonstrated a strong correlation between the dosimetric parameters derived from plan 1 and plan 2 with r > 0.9. The 2D γ analysis showed that the difference between plan 1 and plan 2 could reach ± 10%. The γ evaluation showed a high impact of density correction for left breast cancer with gating technique.

Conclusion: This study confirms that using the MB method integrated with a PBC algorithm, the calculated dose will be increased to target volumes, lung and heart. Even more so since gating usually tends to decrease average lung density by about 39% by treating during an arrested inspiration phase. Thus, attention should be paid when changing from PBC to newer algorithms with gating techniques, since the probability of cardiac mortality and lung toxicity are correlated to absorbed dose.


Heterogeneity Correction for Breast, Gating Method

Full Text:



Korreman SS, Pedersen AN, Nottrup TJ, et al. Breathing adapted radiotherapy for breast cancer: comparison of free breathing gating with the breath-hold technique. Radiother Oncol. 2005;76:311-8.

Korreman SS, Pedersen AN, Josipovic M, et al. Cardiac and pulmonary complication probabilities for breast cancer patients after routine end-inspiration gated radiotherapy. Radiother Oncol. 2006; 80: 257-62.

Chaikh A, Balosso J. Should the dose prescription be readjusted when using tissues density corrections algorithms for radiation oncology? J Case Rep Onc Ther. 2014; 1:01018.

Petillion S, Swinnen A, Defraene G, et al. The photon dose calculation algorithm used in breast radiotherapy has significant impact on the parameters of radiobiological models. J Appl Clin Med Phys. 2014;15:4853.

Basran PS, Zavgorodni S, Berrang T, et al. The impact of dose calculation algorithms on partial and whole breast radiation treatment plans. Radiat Oncol. 2010;5:120.

Fogliata A, Nicolini G, Clivio A, Vanetti E, Cozzi L. On the dosimetric impact of inhomogeneity management in the Acuros XB algorithm for breast treatment. Radiat Oncol. 2011;6:103.

Yoo S, Wu Q, O’Daniel J, et al. Comparison of 3D conformal breast radiation treatment plans using the anisotropic analytical algorithm and pencil beam convolution algorithm. Radiother Oncol. 2012;103:172-7.

Edvardsson A, Nilsson MP, Amptoulach S, Ceberg S. Comparison of doses and NTCP to risk organs with enhanced inspiration gating and free breathing for left-sided breast cancer radiotherapy using the AAA algorithm. Radiat Oncol. 2015;10:84.

Yoon M, Park SY, Shin D, et al. A new homogeneity index based on statistical analysis of the dose–volume histogram. J Appl Clin Med Phys. 2007;8:9-17.

Feuvret L, Noël G, Mazeron JJ, Bey P. Conformity index: a review. Int J Radiat Oncol Biol Phys. 2006;64:333-42.

Chaikh A, Giraud J, Balosso J. A method to quantify and assess the dosimetric and clinical impact resulting from the heterogeneity correction in radiotherapy for lung cancer. Int J Cancer Ther Oncol. 2014; 2:020110.

Gurjar OP, Mishra SP, Bhandari V, et al. Radiation dose verification using real tissue phantom in modern radiotherapy techniques. J Med Phys. 2014;39:44-9.

Low DA, Harms WB, Mutic S, Purdy JA. A technique for the quantitative evaluation of dose distributions. Med Phys. 1998; 25: 656-61.

Spezi E, Lewis DG. Gamma histograms for radiotherapy plan evaluation. Radiother Oncol. 2006;79:224-30.

Chaikh A, Giraud J, Balosso J. A 3D quantitative evaluation for assessing the changes of treatment planning system and irradiation techniques in radiotherapy. Int J Cancer Ther Oncol. 2014; 2:02033.

Chaikh A, Giraud JY, Perrin E, et al. The choice of statistical methods for comparisons of dosimetric data in radiotherapy. Radiat Oncol. 2014;9:205.

Papanikolaou N, Battista J, Mackie T, Kappas C, Boyer A. Tissue inhomogeneity corrections for megavoltage photon beams. AAPM Report No 85; Task Group No. 65, 2004.

Ahnesjö A, Aspradakis MM. Dose calculations for external photon beams in radiotherapy. Phys Med Biol. 1999; 44:99-155.

Batho HF. Lung corrections in cobalt 60 beam therapy. J Can Assoc Radiol. 1964;15:79-83.

El-Khatib E, Battista JJ. Improved lung dose calculation using tissue-maximum ratios in the Batho correction. Med Phys.1984;11:279-86.

Thomas SJ. A modified power low formula for inhomogeneity corrections in beams of high energy x-rays. Med Phys. 1991;18:719-23.

Rana S. Clinical dosimetric impact of Acuros XB and analytical anisotropic algorithm (AAA) on real lung cancer treatment plans: review. Int J Cancer Ther Oncol. 2014;2:02019.

Ojala J. The accuracy of the Acuros XB algorithm in external beam radiotherapy – a comprehensive review. Int J Cancer Ther Oncol. 2014;2:020417.

Rana S, Pokharel S. Dose-to-medium vs. dose-to-water: Dosimetric evaluation of dose reporting modes in Acuros XB for prostate, lung and breast cancer. Int J Cancer Ther Oncol. 2014;2:020421.

DOI: http://dx.doi.org/10.14319/ijcto.41.7

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.


International Journal of Cancer Therapy and Oncology (ISSN 2330-4049)

© International Journal of Cancer Therapy and Oncology (IJCTO)

To make sure that you can receive messages from us, please add the 'ijcto.org' domain to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', check your 'bulk mail' or 'junk mail' folders.


Number of visits since October, 2013